Press Releases

Review corporate releases related to governance, investor news, and other important announcements.

Nov 12, 2026

Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Read more
Nov 09, 2026

CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care

Read more
Nov 06, 2026

CORMEDIX THERAPEUTICS TO REPORT THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON NOVEMBER 12, 2026

Read more
Nov 02, 2026

CORMEDIX THERAPEUTICS PROVIDES BUSINESS UPDATE, REAFFIRMS 2026 TOTAL REVENUE GUIDANCE, AND REPORTS THIRD QUARTER CASH POSITION

Read more
Oct 19, 2026

CORMEDIX ANNOUNCES FDA ACCEPTANCE FOR PRIORITY REVIEW OF SUPPLEMENTAL NDA FOR REZZAYO® (REZAFUNGIN) FOR PROPHYLAXIS OF INVASIVE FUNGAL DISEASES

Read more
Sep 01, 2026

CORMEDIX THERAPEUTICS TO PARTICIPATE IN THE WELLS FARGO HEALTHCARE CONFERENCE

Read more
Aug 13, 2026

CORMEDIX THERAPEUTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Read more
Jul 29, 2026

CORMEDIX THERAPEUTICS TO REPORT SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON AUGUST 13, 2026

Read more
Jun 08, 2026

U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT AFFIRMS VICTORY FOR CORMEDIX THERAPEUTICS IN MINOCIN® PATENT LITIGATION

Read more
May 14, 2026

CORMEDIX THERAPEUTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Read more
See more